INTRODUCTION
============

The integrity of DNA in the cell is under constant threat from physical and chemical agents of endogenous and exogenous origin ([@B1; @B2; @B3; @B4]). Reactive oxygen species (ROS) that escape the cellular metabolism are an important source of DNA damage, which has been involved in pathological processes ([@B5],[@B6]). An oxidized guanine, 7,8-dihydro-8-oxoguanine (8-oxoG), is an abundant and mutagenic lesion in DNA ([@B4],[@B7; @B8; @B9; @B10; @B11]). *In vitro* studies show that 8-oxoG can be bypassed by eukaryotic RNA polymerases or DNA polymerases via incorporation of dCMP or dAMP opposite to 8-oxoG ([@B9],[@B12; @B13; @B14; @B15; @B16; @B17; @B18]). The efficiency of the bypass reaction and the relative incorporation of dCMP *vs* dAMP depend upon the DNA polymerase used and the accessory proteins (PCNA and RPA) present in the reaction mixture ([@B9],[@B12; @B13; @B14; @B15; @B16; @B17; @B18]). *In vivo*, 8-oxoG is thought to be mutagenic, yielding GC to TA transversions, which is consistent with an incorporation of adenine opposite to 8-oxoG ([@B8],[@B11]). To counteract the deleterious effects of 8-oxoG, living organisms have evolved robust DNA repair mechanisms. In *Escherichia coli*, the repair of 8-oxoG mostly relies on two DNA *N*-glycosylases, Fpg and MutY. Fpg is an 8-oxoG DNA *N*-glycosylase/AP lyase that excises 8-oxoG opposite to a cytosine, whereas MutY is an adenine DNA *N*-glycosylase that excises adenine opposite to 8-oxoG ([@B8],[@B9]). Inactivation of both, Fpg and MutY results in a strong GC to TA spontaneous mutator phenotype ([@B8]).

In *Saccharomyces cerevisiae*, the main defense against 8-oxoG is also the base excision repair (BER) pathway initiated by the Ogg1 protein ([@B10],[@B19],[@B20]). Yeast Ogg1 is a functional-albeit not structural-homologue of Fpg ([@B21],[@B22]). Ogg1 is a DNA *N*-glycosylase/AP lyase that excises 8-oxoG and 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyG) from γ-irradiated DNA ([@B23],[@B24]). Finally, inactivation of the Ogg1 protein results in GC to TA spontaneous mutator phenotype ([@B25; @B26; @B27; @B28]). In addition to BER, DNA mismatch repair (MMR) and DNA polymerase η (the *RAD30* gene product) also play a critical role in the prevention of 8-oxoG-induced mutagenesis ([@B26; @B27; @B28]). The *ogg1 msh6* and *ogg1 rad30* double mutants have a synergistic increase in the rate of GC to TA mutations compared with that of the single mutants ([@B26; @B27; @B28]). The data suggest that MMR acts as a functional homologue of the MutY protein of *E. coli*. The Msh2--Msh6 complex recognizes the A.8-oxoG pair with high affinity and initiates the excision of adenine opposite to 8-oxoG ([@B26]). DNA polymerase η is thought to efficiently promote the error-free incorporation of cytosine opposite to 8-oxoG in the course of the DNA gap-filling reaction at the end of the MMR process ([@B27],[@B28]). The *RAD18* and *RAD6* genes also play a prominent role in the network that prevents 8-oxoG-induced mutagenesis in yeast ([@B28]). The *ogg1 rad6* and *ogg1 rad18* double mutants have a synergistic increase in the rate of GC to TA mutations compared with that of the single mutants ([@B28]). The Rad18--Rad6 complex possesses an ubiquitin-conjugating activity that catalyzes the monoubiquitylation of PCNA at lysine K164, which is required for all branches of the post-replication repair (PRR) pathway ([@B29],[@B30]).

In the present study, we explored the molecular events that link PRR and DNA Polymerase η (Rad30/Pol η) to 8-oxoG-induced mutagenesis in *S. cerevisiae*. We investigated the impact on spontaneous Can^R^ mutation rate of a panel of mutants affected in the formation and the recognition of the modified forms of PCNA. The following mutants were tested: *rad5Δ, siz1 Δ, pol30-K164R, pol32Δ, rad30-D570A, rad30-HH-568/572AA, rad30-FF627/628AA* and *rad30-(D570A, FF627/628AA)*. Structural studies of the ubiquitin-binding zinc finger domain (UBZ) of human Pol η suggest that mutation D570A and HH568/H572AA should primarily impair the binding of ubiquitin and the formation of the zinc-finger structure in Pol η from *S. cerevisiae*, respectively ([@B31]). On the other hand, F627 and F628 are essential components of the PCNA-binding domain (PIP) ([@B30]). Our results point to the monoubiquitylation of PCNA at K164 (PCNA-Ub1) as a prerequisite for Pol η\'s ability to prevent 8-oxoG-induced mutagenesis *in vivo*. They also suggest that Pol η\'s antimutator activity requires both the binding of PCNA-Ub1 via its PIP-domain and the binding of the ubiquitin moiety of PCNA-Ub1 via its UBZ-domain. Finally, this study proposes that Pol η and the PRR machinery can also prevent mutagenesis at DNA lesions such as 8-oxoG that do not stall replication forks.

MATERIALS AND METHODS
=====================

Media and growth conditions
---------------------------

Yeast strains were grown at 30°C in YPD medium (1% yeast extract, 1% bactopeptone and 2% glucose, with 2% agar for plates), YNBD medium (0.7% yeast nitrogen base without amino acids and 2% glucose, with 2% agar for plates) supplemented with appropriate amino acids and bases or YNBGal medium (YNB with 2% galactose). Supplemented YNBD medium lacking arginine but containing [l]{.smallcaps}-canavanine (Sigma) at 60 mg/l was used for the selective growth of canavanine-resistant (Can^R^) mutants on plates. Pre-sporulation and sporulation media have been described ([@B32]).

Yeast strains, plasmids and microbiological methods
---------------------------------------------------

*Saccharomyces cerevisiae* strains used in the present study are listed in [Table 1](#T1){ref-type="table"}. All strains are haploid and isogenic to wild type (WT) strains FF18733 (*MATa, leu2-3-112, trp1-289, his7-2, ura3-52, lys1-1, CAN1*) or FF18734 (*MATα, leu2-3-112, trp1-289, his7-2, ura3-52, lys1-1, CAN1*). Gene deletions were performed by a PCR-mediated one-step replacement technique ([@B33],[@B34]). All disruptions were confirmed by PCR on genomic DNA. Strains were also obtained after genetic crossing and tetrad analysis. Micromanipulation and dissection of asci were performed using a Singer MSM System ([@B35]). For biochemical detection of the modified forms of PCNA, the *POL30* open reading frame was replaced at its endogenous locus by a *POL30-His~6~-tagged* allele ([@B36]). For genetic analysis of mutants in the *RAD30* gene, *rad30* or *ogg1 rad30* deletion strains were transformed with a shuttle vector based on YIplac128, which carried WT or mutated *RAD30* gene under the control of the endogenous *RAD30* promoter, for integration into the *LEU2* locus ([@B37]). The empty vector YIplac128 served as control. Plasmids, p990 (YIplac128-Rad30), p991 (YIplac128-rad30-D570A), p1080 (YIplac128-rad30-FF627/628AA) and p1081 (YIplac128-rad30-D570A, FF627/628AA), were as described ([@B37]). Plasmid pBU001 (YIplac128-rad30-HH568/572AA) was derived from p990. Plasmids were restricted at EcoRV, transformed into *rad30Δ* or *ogg1Δ rad30Δ* cells and Leu^+^ transformants were selected and accurate integration was controlled by PCR analysis ([Table 1](#T1){ref-type="table"}). The *mutY* gene of *E. coli* was PCR-amplified from a WT strain (AB1157) and cloned into the pRS415-*GAL1 (CEN ARS LEU2)* plasmid. Mutations were introduced by PCR-based mutagenesis. Details of primers, strains and plasmids are available upon request. Table 1.*Saccharomyces cerevisiae* strains used in this studyStrainGenotypeSourceFF 18733*MATa, leu2-3-112, trp1-289, his7-2, ura3-52, lys1-1*F. FabreFF 18734*MATα, leu2-3-112, trp1-289, his7-2, ura3-52, lys1-1*F. FabreCD 138FF 18733 *with ogg1Δ::TRP1*This studyBPS 1002FF 18733 *with, rad18Δ::kanMX6*This studyBPS 1119FF 18733 *with ogg1Δ::TRP1, rad18Δ::kanMX6*This studyBG 177FF 18734 *with rad51Δ::LEU2*This studyBA 009FF 18734 *with ogg1Δ::TRP1, rad51Δ::LEU2*This studyBPS 1029FF 18733 *with pol32Δ::kanMX6*This studyBPS 1056FF 18733 *with ogg1Δ::TRP1, pol32Δ::kanMX6*This studyBS 4FF 18733 *with rad5Δ::URA3*This studyBA 007FF 18733 *with ogg1Δ::TRP1, rad5Δ::URA3*This studyBA 004FF 18734 *with siz1Δ::URA3*This studyBA 005FF 18734 *with ogg1Δ::TRP1, siz1Δ::URA3*This studyFF182028FF 18734 *with pol30-K164R*F. FabreBPS 1117FF 18734 *with ogg1Δ::TRP1, pol30-K164R*This studyBPS 1059FF 18734 *with ogg1Δ::TRP1, rad18Δ::kanMX6, pol32::kanMX6*This studyBPS 1011FF 18733 *with rad30Δ::kanMX6*This studyBPS 1063FF 18733 *with ogg1Δ::TRP1, rad30Δ::kanMX6*This studyBU001[^a^](#TF1){ref-type="table-fn"}FF 18733 *with POL30-His6-tag*This studyBU002FF 18733 *with ogg1Δ::TRP1 POL30-His6-tag*This studyBU003FF 18733 *with msh6Δ::kanMX6 POL30-His6-tag*This studyBU004FF 18733 *with ogg1Δ::TRP1 msh6Δ::kanMX6 POL30-His6-tag*This studyBU005FF 18733 *with apn1Δ::LEU2 apn2Δ::kanMX6 POL30-His6-tag*This studyBU006FF 18733 *with rad30Δ::kanMX6 LEU2*This studyBU007FF 18733 *with rad30Δ::kanMX6 LEU2 RAD30*This studyBU008FF 18733 *with rad30Δ::kanMX6 LEU2 rad30-D570A*This studyBU009FF 18733 *with rad30Δ::kanMX6 LEU2 rad30-HH568/572AA*This studyBU010FF 18733 *with rad30Δ::kanMX6 LEU2 rad30-FF627/628AA*This studyBU011FF 18733 *with rad30Δ::kanMX6 LEU2 rad30-(D570A, FF627/628A)*This studyBU012FF 18733 *with ogg1Δ::TRP1 rad30Δ::kanMX6 LEU2*This studyBU013FF 18733 *with ogg1Δ::TRP1 rad30Δ::kanMX6 LEU2 RAD30*This studyBU014FF 18733 *with ogg1Δ::TRP1 rad30Δ::kanMX6 LEU2 rad30-D570A*This studyBU015FF 18733 *with ogg1Δ::TRP1 rad30Δ::kanMX6 LEU2 rad30-HH568/572AA*This studyBU016FF 18733 *with ogg1Δ::TRP1 rad30Δ::kanMX6 LEU2 rad30-FF627/628AA*This studyBU017FF 18733 *with ogg1Δ::TRP1 rad30Δ::kanMX6 LEU2 rad30-(D570A,FF627/628A)*This study[^1]

Spontaneous mutation rates
--------------------------

For each strain, 11 independent cultures were inoculated with about 5 × 10^2^ cells in 2 ml of YPD, YNBD or YNBGal medium and grown at 30°C for 3 days. Cell density was measured by plating dilutions on YPD or YNBD agar plates and counting the colonies after 3 days at 30°C. The quantification of canavanine-resistant mutants (Can^R^) was determined after plating on selective medium (YNBD agar plates containing 60 mg/l [l]{.smallcaps}-canavanine) ([@B38]). Colonies were counted after 4--5 days at 30°C. All experiments were repeated independently 2--5 times. Mutation rates were determined from the number of Can^R^ colonies by the method of the median ([@B39]).

Mutation spectra
----------------

For each strain, 32 independent cultures were grown and plated onto [l]{.smallcaps}-canavanine-containing plates (one culture per plate). After 3 days at 30°C, a single Can^R^ mutant colony per plate was isolated and streaked onto selective canavanine-containing plates. Genomic DNA was extracted from saturated 1.5 ml YPD cultures obtained from individual colonies isolated from the canavanine-containing plates using ZymolyaseR (ICN) and the DNeasy Tissue Kit (Qiagen). The *CAN1* gene was amplified by PCR from genomic DNA with 5-CAN-40 (5′CAGACTTCTTAACTCCTG3′) and 3-CAN1880 (5′GAAATGTGATCAAAGGTA-ATAAAACG3′). Sequencing of the *CAN1* gene (1773 base pairs) was performed using three primers as previously described ([@B28],[@B40]). Sequence alignment and analysis were performed using the DNA-STRIDER program.

MutY activity assay
-------------------

A 34-mer oligodeoxyribonucleotide containing a single 8-oxoG at position 16 \[5′-GGCTTCATCGTTGT-8-oxoG-CAGACCTGGTGGATACCG-3′\] (a kind gift of Dr J. Cadet, CEA-Grenoble, France) and its complementary sequence with an adenine (A) at position 19 were used to generate a double stranded DNA substrate with a single A.8-oxoG pair. Before annealing the A-containing complementary strand was \[^32^P\]-labeled at the 5′-end as described ([@B41]). The assay mixture (15 μl final volume) contained 25 mM Tris--HCl pH 7.6, 100 mM NaCl, 50 fmol \[^32^P\]-labeled A.8-oxoG duplex and limited amounts of cell free extract of WT cells hosting pRS415-*GAL1* or pRS415-*GAL1-mutY* plasmid. To express the MutY protein, cells were grown at 30°C in YNBGal medium in absence of leucine until OD~600~ = 1.0. Cell free extracts were prepared as described ([@B42]). The reactions were performed at 37°C for 15 min. Then, 6 μl of formamide dye was added before heating at 95°C for 5 min. The product of the reaction (P) was separated from the substrate (S) by 20% PAGE containing 7 M urea and quantified using a Molecular Dynamics PhosphorImager ([@B41]).

Detection of PCNA modifications
-------------------------------

The *POL30* open reading frame was replaced at its endogenous locus by a His~6~-tagged allele in WT or *msh6, ogg1, msh6 ogg1* and *apn1 apn2* deletion mutant strains ([Table 1](#T1){ref-type="table"}). Exponentially growing cultures, about 10^9^ cells, were prepared. Cells were either untreated or exposed to 0.02% methyl-methane sulfonate (MMS) for 90 min at 30°C. Cells were harvested and processed essentially as previously described ([@B36]). Briefly, cells were lysed under denaturing conditions, and ^His^PCNA and its modified forms were isolated by Ni-NTA affinity chromatography from the total extracts. Samples were separated on NuPAGE™ 4--12% Bis-Tris gradient gels (Invitrogen), followed by Western blotting with polyclonal antibodies against yeast PCNA and a commercial monoclonal anti-ubiquitin antibody, P4D1 (Cell Signaling Technologies) ([@B36]).

Two-hybrid analysis
-------------------

Analysis of protein--protein interactions in the two-hybrid system was performed in PJ64-4A, as described previously ([@B37]). Bait and prey plasmids carrying PCNA\* (KK127/164RR) and fusions thereof to ubiquitin\* (KKK29/48/63RRR) as well as WT and mutant (D570A) versions of Rad30 (Pol η), either full-length (1--632) or truncated (538--632), have been described ([@B37]). The mutant (HH568/572AA) of Rad30 was constructed analogously. Selection for the presence of the bait and prey plasmids was carried out on synthetic medium lacking tryptophan and leucine (-LW), and positive interactions were scored by growth on medium further lacking histidine (-HLW) or histidine and adenine (-AHLW).

RESULTS
=======

Monoubiquitylation of PCNA at K164 is required to prevent high spontaneous mutation rates in Ogg1-deficient strains of *S. cerevisiae*
--------------------------------------------------------------------------------------------------------------------------------------

We recently reported that the *RAD18* and *RAD6* genes are important components of the cellular network that prevents 8-oxoG-induced mutagenesis in Ogg1-deficient strains of *S. cerevisiae* ([@B28]). The Rad18--Rad6 complex possesses an ubiquitin-conjugating activity that catalyzes the monoubiquitylation of PCNA at lysine K164, which is required for all branches of the post-replication repair process ([@B29],[@B30],[@B43],[@B44]). Here, we investigated the impact of the K164R mutation of PCNA (*POL30* gene product) that abolishes the conjugation of ubiquitin to PCNA and greatly reduces that of SUMO ([@B29],[@B30],[@B43],[@B44]). The results show that the *ogg1 pol30-K164R* double mutant, like *ogg1 rad18* and *ogg1 rad30*, exhibits a synergistic increase in Can^R^ mutation rate compared to that of the single mutants ([Table 2](#T2){ref-type="table"}). In contrast, the *ogg1 rad5* and *ogg1 siz1* double mutants do not exhibit a synergistic increase in Can^R^ mutation rates compared to that of the single mutants ([Table 2](#T2){ref-type="table"}). These results suggest that neither Rad5-dependent polyubiquitylation nor Siz1-dependent sumoylation of PCNA is involved in the prevention of 8-oxoG-induced mutagenesis in Ogg1-deficient cells. [Table 2](#T2){ref-type="table"} also shows that homologous recombination does not play a critical role in the antimutagenic process at 8-oxoG, since the spontaneous mutation rate in the *ogg1 rad51* double mutant corresponds to the sum of the rates in the two single mutants. These results are in agreement with the notion that only monoubiquitylation of PCNA (PCNA-Ub1) at K164 plays an important role in the process that prevents high spontaneous mutation rates in *S. cerevisiae*. Table 2.Spontaneous Can^R^ mutation rate in strains that cannot undergo ubiquitin- or SUMO-conjugation of PCNA in *S. cerevisiae*Relevant genotypeCan^R^ mutation rate × 10^−7^Ratio[^a^](#TF2){ref-type="table-fn"}*Wild type*4.4 (3.8--5.0)1.0*Δogg1*17.4 (13.4--24.8)4.0*Δrad18*11.4 (8.2--18.6)2.6*Δrad5*12.8 (10.4--16.2)2.9*Δsiz1*2.4 (2.2--3.2)0.5*Δrad51*51.8 (39.2--74.6)11.7*Δrad30*6.0 (5.0--9.4)1.4*pol30-K164R*3.6 (2.8--4.8)0.8*Δogg1Δrad18*70.6 (61.4--95.0)16.0[^b^](#TF3){ref-type="table-fn"}*Δogg1Δrad5*29.8 (24.4--40.2)6.8*Δogg1Δsiz1*17.2 (13.8--20.4)3.9*Δogg1Δrad51*66.6 (53.6--69.8)15.1*Δogg1Δrad30*57.0 (43.2--70.6)13.0[^b^](#TF3){ref-type="table-fn"}*Δogg1 pol30-K164R*58.0 (52.2--68.9)13.2[^b^](#TF3){ref-type="table-fn"}[^2][^3][^4]

Spectrum of Can^R^ mutations in pol30-K164R and ogg1 pol30-K164R strains
------------------------------------------------------------------------

If 8-oxoG is at the origin of the high spontaneous Can^R^ mutation rate measured in the *ogg1 pol30-K164R* double mutant, the spectrum of mutations should be strongly biased in the favor of GC to TA ([@B28]). To test this hypothesis, sequence analysis of Can^R^ mutations was performed in the *pol30-K164R* and *ogg1 pol30-K164R* mutant strains ([Table 3](#T3){ref-type="table"}). The results show that the spectrum of Can^R^ mutations in the *ogg1 pol30-K164R* double mutant is nearly exclusively composed of GC to TA (96.9%), resulting in a 74-fold increase compared to the WT ([Table 3](#T3){ref-type="table"}). This spectrum is very similar to those obtained with the *ogg1 rad18* and *ogg1 rad30* double mutants ([@B28]), which points to 8-oxoG as the cause of spontaneous GC to TA in the *ogg1 pol30-K164R* strain. The results also show that the overall Can^R^ mutation rate in the *pol30-K164R* mutant is not significantly different from that of the WT ([Table 2](#T2){ref-type="table"}). However, we observe a 2.2-fold increase in GC to TA in the *pol30-K164R* compared to the WT ([Table 3](#T3){ref-type="table"}). Similarly, a 1.8-fold increase in GC to TA was observed in the *rad30* mutant compared to the WT ([@B28]). Although modest, these increases in GC to TA in *pol30-K164R* and *rad30Δ* suggest that a minor fraction of 8-oxoG escape the vigilance of Ogg1 and reveal the other pathways even in Ogg1-proficient cells. Table 3.Spectrum of Can^R^ mutationsGenotypeMutationOccurrenceMutation rate × 10^−7^[^a^](#TF4){ref-type="table-fn"}*Wild type*GC to TA5/29 (17.2%)0.76 (1.0)[^b^](#TF5){ref-type="table-fn"}GC to CG5/29 (17.2%)0.76GC to AT8/29 (27.6%)1.21AT to TA1/29 (3.4%)0.15AT to CG3/29 (10.3%)0.45AT to GC1/29 (3.4%)0.15(-1) deletion3/29 (10.3%)0.45Insertion1/29 (3.4%)0.15Complex[^c^](#TF6){ref-type="table-fn"}2/29 (6.8%)0.30*ogg1*GC to TA25/30 (83.3%)14.49 (19.1)GC to AT3/30 (10.0%)1.74AT to TA1/30 (3.3%)0.57Deletion1/30 (3.3%)0.57*pol30-K164R*GC to TA15/32 (46.8%)1.68 (2.2)GC to CG3/32 (9.4%)0.34GC to AT9/32 (28.1%)1.01AT to TA2/32 (6.3%)0.23AT to CG1/32 (3.1%)0.11AT to GC1/32 (3.1%)0.11Insertion1/32 (3.1%)0.11*ogg1 pol30-K164R*GC to TA31/32 (96.9%)56.2 (73.9)GC to CG1/32 (3.1%)1.80[^5][^6][^7]

Suppression of 8-oxoG-induced mutagenesis by the MutY protein of *E. coli*
--------------------------------------------------------------------------

The synergistic increase in spontaneous GC to TA observed in *ogg1 rad18* and *ogg1 pol30-K164R* is most probably due to 8-oxoG. However the role of another DNA lesion with the same coding properties cannot be completely ruled out. To further confirm 8-oxoG as the cause of Can^R^ mutations in various yeast mutants, we explored the capacity of the MutY protein of *E. coli* to suppress spontaneous mutagenesis in *S. cerevisiae*. The MutY protein of *E. coli* is an adenine DNA *N*-glycosylase that specifically recognizes A.8-oxoG pairs in DNA ([@B8]). Amongst eukaryotes, most organisms including man possess a MutY-homolog with the considerable exception of *S. cerevisiae* ([@B11]). Genetic and biochemical data point to MMR as the functional homolog of MutY in *S. cerevisiae* ([@B26]). Here, we cloned the *mutY* gene of *E. coli* in the pRS415-*GAL1* plasmid yielding pRS41*5-GAL1-mutY*, which was used to transform the WT strain of *S. cerevisiae*. [Figure 1](#F1){ref-type="fig"} shows that cell free extract of WT/pRS415-*GAL1* does not exhibit detectable MutY activity. This result is in agreement with the notion that *S. cerevisiae* does not possess a known or unknown DNA N-glycosylase able to excise adenine opposite to 8-oxoG. In contrast, cell free extract of WT/pRS415-*GAL1-mutY* possesses a robust MutY activity ([Figure 1](#F1){ref-type="fig"}). Control experiments show that the MutY activity in extracts is undetectable when WT/pRS415-GAL1-*mutY* cells are grown in the presence of glucose instead of galactose (data not shown). Figure 1.Expression of the MuY protein of *E. coli* in *S. cerevisiae*. WT strain of *S. cerevisiae* harboring p415-*GAL1* or p415-*GAL1-mutY* was grown at 30°C in YNBGal supplemented medium until OD~600~ = 1.0. Cell free extracts were prepared and assayed for MutY activity using a 34-mer DNA duplex that contained a single A\*.8-oxoG pair. Total protein concentration in extracts was as follows: WT/p415-*GAL1* (4.2 mg/ml) and WT/p415-*GAL1-mutY* (3.8 mg/ml). **S**: 34-mer Substrate, **P**: 19-mer Product. A\*: the A-containing strand was \[^32^P\]-labeled at the 5′-end.

[Table 4](#T4){ref-type="table"} shows that MutY has no significant effect on the overall Can^R^ mutation rate in WT, *rad18* or *pol30-K164R* strains. Although biased in favor of GC to TA, the spontaneous mutator phenotype of *rad18* is most likely not due to 8-oxoG but to other endogenous DNA damage(s) or structure(s) ([@B28],[@B45]). In contrast, the MutY protein greatly reduces spontaneous Can^R^ mutation rate in the *ogg1* single mutant, which is expected if Can^R^ mutations are due to 8-oxoG ([Table 4](#T4){ref-type="table"}). [Table 4](#T4){ref-type="table"} also shows that the expression of MutY only partially suppresses spontaneous mutagenesis (to the *rad18* level) in the *ogg1 rad18* double mutant, which confirms the impact of another class of damage at the origin of mutations in Rad18-deficient cells. Finally, the expression of MutY completely suppresses (to the WT level) spontaneous mutagenesis in the *ogg1 pol30-K164R* double mutant ([Table 4](#T4){ref-type="table"}). Therefore, both the mutation spectrum and the suppression of the mutator phenotype by MutY point to 8-oxoG as the major cause of mutations in the *ogg1 pol30-K164R* double mutant. Table 4.The MutY protein of *E. coli* suppresses 8-oxoG-induced mutagenesis in *S. cerevisiae*Relevant genotypeCan^R^ mutation rate × 10^−7^Ratio[^a^](#TF7){ref-type="table-fn"}*Wild type/p415-GAL1*3.6 (3.2--7.5)1.0*Wild type/p415-GAL1-mutY*4.1 (2.4--6.2)1.1*Δogg1/p415-GAL1*19.5 (15.2--22.6)5.4*Δogg1*/p415-*GAL1-mutY*2.9 (2.3--3.5)0.8*Δrad18/p415-GAL1*10.1 (6.8--11.9)2.8*Δrad18*/p415*-GAL1-mutY*9.4 (7.7--11.2)2.6*pol30-K164R/p415-GAL1*5.1 (4.0--6.7)1.4*pol30-K164R*/*p415-GAL1-mutY*3.9 (3.4--4.6)1.1*Δogg1Δrad18/p415-GAL1*60.6 (49.9--72.6)16.8*Δogg1Δrad18/p415-GAL1-mutY*15.5 (12.4--22.3)4.3*Δogg1 pol30-K164R/p415-GAL1*68.1 (51.7--84.5)21.7*Δogg1 pol30-K164R/p415-GAL1-mutY*4.9 (4.2--5.9)1.4[^8][^9]

Ubiquitylation of PCNA in strains unable to repair 8-oxoG or AP sites
---------------------------------------------------------------------

Our genetic analysis shows that monoubiquitylated PCNA (PCNA-Ub1) is an important player in the error-free processing (TLS) of 8-oxoG in *S. cerevisiae*. These results point to the formation of PCNA-Ub1 in untreated Ogg1-deficient cells at presumably low but potentially detectable levels. Since 8-oxoG is not thought to be a strong block to DNA replication, the formation of PCNA-Ub1 could occur in the course of the gap-filling synthesis after MMR-dependent excision of adenine paired with 8-oxoG ([@B26; @B27; @B28]). Therefore, if detectable under normal growth condition, the level of PCNA-Ub1 should be higher in an *ogg1* single mutant than in an *ogg1 msh6* double mutant. To identify the ubiquitylated forms of PCNA (PCNA-Ub) in yeast cells, the *POL30* (PCNA) open reading frame was replaced at its endogenous locus by a His~6~-tagged allele. The presence of PCNA-Ub was monitored using affinity chromatography-purified PCNA and Western blotting with polyclonal antibodies against yeast PCNA and monoclonal anti-ubiquitin antibody ([@B36]). [Figure 2](#F2){ref-type="fig"}A shows that PCNA-Ub cannot be detected in untreated WT, *ogg1, msh6 or ogg1 msh6* cells. This is probably due to the fact that the signal is below the limit of detection of the western blotting assay. Control experiments show the formation of mono- and polyubiquitylated PCNA (PCNA-Ubn) in all four strains after exposure to 0.02% MMS ([Figure 2](#F2){ref-type="fig"}A). SUMO-PCNA is also observed in all strain tested either untreated or exposed to 0.02% MMS ([Figure 2](#F2){ref-type="fig"}). Therefore, the absence of detectable PCNA-Ub in Ogg1-deficient cells does not allow conclusions about the role of MMR in the formation of PCNA-Ub during the processing of 8-oxoG. Figure 2.Ubiquitylation of PCNA in mutator strains of *S. cerevisiae*. Asynchronous exponentially growing untreated (no damage) cells were allowed to grow at 30°C until OD600 = 1.0. MMS-treated cells were exposed to 0.02% MMS for 90 min at 30°C. Crude extracts from untreated and MMS-treated cells were prepared under denaturing conditions. ^His^PCNA was isolated and its modifications were detected by Western blotting with anti-PCNA and anti-ubiquitin antibodies. Migration of the ubiquitylated forms of PCNA (PCNA-Ub1, PCNA-Ub2 and PCNA-Ubn) and sumoylated forms of PCNA (PCNA-S) are indicated ([Figure 2](#F2){ref-type="fig"}, right). Migration of molecular weight markers (kDa) is indicated ([Figure 2](#F2){ref-type="fig"}, left). (**A**) WT, *ogg1*, *msh6*, *msh6 ogg1* ^His^-PCNA strains untreated and MMS (0.02%) treated. (**B**) WT and *apn1 apn2* ^His^-PCNA strains untreated and MMS (0.02%) treated.

For comparison, we also His-tagged PCNA in the *apn1 apn2* double mutant, another spontaneous mutator strain in *S. cerevisiae* ([@B3],[@B46]). [Figure 2](#F2){ref-type="fig"}B shows the presence of PCNA-Ubn in untreated *apn1 apn2* double mutant, which is deficient in the repair of abasic (AP) sites ([@B3]). Interestingly, the Can^R^ mutation rate in *apn1 apn2* \[9.4 x 10^−7^ (6.6--15.2)\] is comparable to that observed in *ogg1* ([Table 2](#T2){ref-type="table"}). Therefore, the comparison of *ogg1* and *apn1 apn2* reveals that spontaneous mutation rates and levels of PCNA-Ub in untreated cells are not correlated. This result probably reflects the properties of the DNA lesions, 8-oxoG versus AP site, at the origin of the mutational events. These data support the notion that 8-oxoG does not act as a block to replication forks *in vivo* whereas AP site does.

UBZ and PIP domains of DNA polymerase η are required to prevent 8-oxoG-induced mutagenesis
------------------------------------------------------------------------------------------

Our genetic data point to a model that involves Rad18--Rad6 and PCNA-Ub1 in a cellular process that prevents 8-oxoG-induced mutagenesis. PCNA-Ub1 could be used to specifically recruit Pol η to perform the translesion synthesis (TLS) with error-free incorporation of dCMP opposite to 8-oxoG ([@B27],[@B28]). Indeed, the recruitment of specialized DNA polymerases by PCNA-Ub1 is a widely accepted mechanism to explain DNA synthesis across DNA lesions that stall replication forks such as pyrimidine dimer ([@B29],[@B30]). In order to investigate the impact of the interactions between Pol η and PCNA on 8-oxoG-induced mutagenesis, we used mutant versions of Pol η that are affected in the PCNA-interacting domain (PIP) or in the ubiquitin-binding zinc finger domain (UBZ) ([@B37],[@B47]). The PIP-domain mutant used here (FF627/628AA) has already been demonstrated to be deficient in its TLS function after UVC-irradiation *in vivo* ([@B48]). Based on structural information, we used two types of mutant versions of Pol η affected in the UBZ-domain ([@B31]). According to this study, mutation D570A should primarily affect the interaction between Pol η and ubiquitin, whereas HH568/572AA should abrogate the formation of the putative zinc-finger structure, respectively ([@B31]). Whereas the D570A mutation had previously been demonstrated to be deficient in TLS and ubiquitin binding ([@B37],[@B47]), no measurable UVC sensitivity was found for HH568/572AA indicating functional TLS ([@B47]). Yeast strains that express WT and mutant versions of Pol η were constructed and spontaneous Can^R^ mutation rates were determined. [Figure 3](#F3){ref-type="fig"}A shows that the expression of Pol η WT and mutants in *rad30* cells does not significantly impact on Can^R^ mutation rates. [Figure 3](#F3){ref-type="fig"}B shows that the expression of Pol η-WT and Pol η-HH568/572AA in *ogg1 rad30* cells greatly reduces, to the level of an *ogg1* single mutant, the spontaneous Can^R^ mutation rates. In contrast, the expression of Pol η-D570A, Pol η-FF627/628AA and Pol η-(D570A, FF627/628AA) does not result in a significant reduction of Can^R^ mutation rates in *ogg1 rad30* cells ([Figure 3](#F3){ref-type="fig"}B). These results strongly suggest a critical role of both the UBZ and the PIP domain of Pol η to prevent 8-oxoG-induced mutagenesis in *S. cerevisiae*. They also correlate with the UVC sensitivities of the respective mutants reported previously ([@B37],[@B47]). Figure 3.The UBZ- and PIP-domains of Pol η are required to prevent 8-oxoG-induced mutagenesis. Strains bearing a *rad30* deletion (**A**) or *ogg1 rad30* deletions (**B**) were complemented by expressing a chromosomal version of Rad30-WT, Rad30-D570A, Rad30-FF627/628AA (PIP\*), Rad30-(D570A, PIP\*) and Rad30-HH568/572AA placed under the control of its natural promoter. Strains are described in 'Materials and methods' section and [Table 1](#T1){ref-type="table"}. Can^R^ mutation rates were determined as described ([Table 2](#T2){ref-type="table"}). *Δ ogg1* Can^R^ mutation rate value: 17.4 × 10^−7^ (13.4--24.8).

Although essential, the precise role of the UBZ domain of Pol η in the TLS process remains unclear. Indeed, the mutational inactivation of the zinc binding ability of Pol η-HH568/572AA was expected to abolish its ubiquitin-binding ability raising the question of whether ubiquitin binding was in fact required for TLS ([Figure 3](#F3){ref-type="fig"} and ref. 47). Here, we compared the capacity of Pol η-WT, Pol η-D570A and Pol η-HH568/572AA to interact with PCNA and PCNA-Ub in the two-hybrid system. [Figure 4](#F4){ref-type="fig"} shows the interactions between the different versions of Pol η, PCNA\* and linear fusions of ubiquitin to PCNA\* (Ub\*-PCNA\* and PCNA\*-Ub\*). As previously reported ([@B37]), fusion of ubiquitin to PCNA significantly enhances interaction with Pol η in an UBZ-dependent manner. Hence, Pol η-WT fused to *GAL4-AD* in combination with Ub\*-PCNA\* or PCNA\*-Ub\* fused to *GAL4-BD* activates the *HIS3* reporter gene, whereas interactions with PCNA\* alone or those involving the Pol η-D570A mutation are too weak to give a signal ([Figure 4](#F4){ref-type="fig"}A). Reversal of the orientation in the two-hybrid system results in coherent but overall stronger signals, where Pol η fused to *GAL4-BD* in combination with PCNA\* alone fused to *GAL4-AD* activates the *HIS3* reporter ([Figure 4](#F4){ref-type="fig"}B). Preferential binding of Pol η-WT to the ubiquitin fusions is now observed on plates selecting for activation of the *HIS3* and *ADE2* reporters. Under this assay condition (-AHLW), Pol η-D570A does not generate a detectable signal with Ub\*-PCNA\* or PCNA\*-Ub\*, whereas Pol η-HH568/572AA and Pol η-WT efficiently bind Ub\*-PCNA\* or PCNA\*-Ub\* ([Figure 4](#F4){ref-type="fig"}B). We also performed these two-hybrid assays with the full-length proteins, Rad30(1--632), with identical results (ref. 37 and data not shown). These results led us to conclude that mutation D570A in the UBZ domain of Pol η adversely affects its capacity to bind PCNA-Ub, whereas mutation HH568/572AA does not. Taken together, our data suggest that Pol η\'s capacity to suppress 8-oxoG-induced mutagenesis correlates with its capacity to directly bind the ubiquitin moiety on linear Ub-PCNA fusions. They also suggest that the putative Zn-finger structure in the UBZ domain of Pol η is not required for ubiquitin binding and for TLS of 8-oxoG in *S. cerevisiae*. Figure 4.Physical interactions between Rad30-WT, Rad30-D570A, Rad30-HH568/572AA and PCNA\*, Ub\*-PCNA\* or PCNA\*-Ub\* fusions. Interactions were monitored in the two-hybrid system, based on fusions to the *GAL4* activation (AD) and *GAL4* DNA-binding (BD) domains. Truncated *RAD30*, comprising amino acids 538--632, either WT or mutant (D570A and HH568/572AA) were used. Mutated PCNA (PCNA\*) and linear fusions of mutated ubiquitin and PCNA at the N-terminus (Ub\*-PCNA\*) or the C-terminus (PCNA\*-Ub\*) were fused to *GAL4*-AD and *GAL4*-BD \['Materials and Methods' section ([@B37])\]. Interactions were scored by growth on plates lacking histidine (-HLW) and plates lacking histidine and adenine (-AHLW). Plates were scored after 3 days at 30°C. (**A**) Rad30 (538--632) fused to *GAL4*-AD. (**B**) Rad30 (538--632) fused to *GAL4*-BD.

Impact of DNA Polymerase δ subunit (Pol32) on 8-oxoG-induced mutagenesis
------------------------------------------------------------------------

Our model suggests a competition between DNA polymerases δ (Pol δ) and η to bind PCNA or PCNA-Ub1 during the gap-filling reaction after the MMR-dependent excision of A.8-oxoG mismatches ([@B28]). The role of Pol δ cannot be directly addressed because of its essential function in *S. cerevisiae*. However, one of the three subunits of Pol δ, Pol32, is non-essential and can be deleted ([@B49],[@B50]). We therefore investigated the impact of the Pol32 protein on spontaneous Can^R^ mutation rate in *ogg1* and *ogg1 rad18* backgrounds. [Table 5](#T5){ref-type="table"} shows that the *ogg1 pol32* double mutant does not exhibit an enhanced Can^R^ spontaneous mutation rate, compared to an *ogg1* single mutant. Interestingly, the Can^R^ mutation rate is greatly reduced in the *ogg1 rad18 pol32* triple mutant compared to the *ogg1 rad18* double mutant ([Table 5](#T5){ref-type="table"}). We propose that in the absence of PCNA-Ub1 in the *ogg1 rad18* strain, both Pol δ and Pol η are recruited at unmodified PCNA allowing significant dAMP incorporation opposite to 8-oxoG, which explains the enhanced mutagenesis in the *ogg1 rad18* strain. In the *ogg1 rad18 pol32* triple mutant, the recruitment of Pol η at unmodified PCNA could be favored because of the loss of affinity of Pol δ for PCNA in absence of its Pol32 subunit, which also possesses a PIP domain ([@B50]). Consequently, the shift in favor of Pol η would promote dCMP incorporation and explain the reduced Can^R^ mutation rate in the *ogg1 rad18 pol32* triple mutant. Table 5.Impact of Pol32 on Can^R^ mutation rates in *S. cerevisiae*Relevant genotypeCan^R^ mutation rate × 10^−7^Ratio[^a^](#TF8){ref-type="table-fn"}*Wild type*4.4 (3.8--5.0)1.0*Δogg1*17.4 (13.4--24.8)4.0*Δrad18*11.4 (8.2--18.6)2.6*Δpol32*4.6 (4.2--5.6)1.0*Δogg1Δrad18*70.6 (61.4--95.0)16.0*Δogg1Δpol32*17.8 (14.4--23.8)4.0*Δogg1Δrad18Δpol32*26.6 (23.4--36.4)6.0[^10][^11]

DISCUSSION
==========

The aim of our studies is to decipher the biological network that protects the genome from the deleterious action of 8-oxoG in eukaryotic cells. In *S. cerevisiae*, this network involves at least four components: the 8-oxoG DNA *N*-glycosylase (Ogg1), the Msh2--Msh6-dependent MMR, the Rad18--Rad6 complex and the DNA polymerase η ([@B26; @B27; @B28]). Ogg1 is the major player and the only one able to remove 8-oxoG from DNA, which may explain why the contribution of other partners is unambiguously assessed only in Ogg1-deficient cells. Recently, we proposed a model ([@B28]): (i) due to endogenous oxidative stress, 8-oxoG forms in genomic DNA, (ii) DNA polymerase δ in the presence of auxiliary proteins present at the replication fork efficiently incorporates adenine opposite to 8-oxoG, (iii) Msh2--Msh6 complex recognizes the A.8-oxoG pairs and initiates the MMR-dependent excision of the adenine paired with 8-oxoG, which results in the formation of a gapped-structure with 8-oxoG in a single-stranded DNA (ssDNA) region and (iv) During repair synthesis, the Rad18--Rad6 complex promotes the recruitment of Pol η, which incorporates a cytosine across from the lesion, preventing mutation fixation and regenerating the 8-oxoG.C pair substrate of Ogg1. Although attractive, this model presents a major caveat since it does not provide information about the molecular mechanisms that allow the specific recruitment of Pol η at the site of the lesion.

In the present study, we show that the *ogg1 pol30-K164R* double mutant exhibits a synergistic increase in spontaneous Can^R^ mutation rate, compared to the single mutants. Our results unambiguously point to 8-oxoG as the primary cause for the high Can^R^ mutation rate in the *ogg1 pol30-K164R* strain: (i) the spectrum of Can^R^ mutations in *ogg1 pol30-K164R* is nearly exclusively composed of GC to TA and (ii) the high Can^R^ mutation rate in *ogg1 pol30-K164R* is reduced to the WT level upon expression of the bacterial MutY protein. These data led us to conclude that modification of PCNA at lysine K164 is a critical component of the cellular network that prevents 8-oxoG-induced mutagenesis. In fact, the K164R mutation of PCNA abolishes the formation of all kinds of PCNA-Ub and greatly reduces that of PCNA-SUMO ([@B29],[@B30]). Here, we show that neither *rad5* nor *siz1* synergizes with *ogg1*, leading us to conclude that neither polyubiquitylated PCNA nor SUMO-PCNA is critical to prevent mutations at 8-oxoG. On the other hand, they strongly suggest that monoubiquitylation of PCNA (PCNA-Ub1) is essential.

Our genetic analysis points to the formation of PCNA-Ub1 in the course of the error free processing (TLS) of 8-oxoG. To investigate this issue at the biochemical level, we measured by western blotting the formation of PCNA-Ub in an *ogg1* deletion mutant. For comparison, we also tested an *apn1 apn2 mutant*, unable to repair AP sites. Unfortunately, untreated *ogg1* cells do not exhibit detectable amounts of PCNA-Ub, like WT cells, which do not allow us to provide further information about the mechanisms of formation of PCNA-Ub1 during the processing of 8-oxoG. In contrast, untreated *apn1 apn2* cells present detectable level of PCNA-Ubn. These results may suggest that 8-oxoG does not efficiently stall replication forks, whereas the AP site does ([@B3]). This is in favor of a model where PCNA-Ub1 forms during the gap-filling reaction after the MMR-dependent excision of adenine opposite to 8-oxoG. Indeed, this model relies on consistent but circumstantial evidence ([@B26; @B27; @B28]) and its remains possible that the role of PCNA-Ub1 and Pol η also occurs at the stage of replication. The impact of 8-oxoG on DNA replication is also probably modulated by the sequence context around the lesion.

However, most *in vitro* and *in vivo* studies support the notion that the majority of the error-free TLS events at 8-oxoG occur in the course of a gap-filling reaction after MMR ([@B12; @B13; @B14; @B15; @B16; @B17; @B18],[@B26; @B27; @B28]). MMR-dependent excision of adenine opposite to 8-oxoG results in the formation of stretches of ssDNA coated with RPA that might be used to activate Rad18--Rad6 and cause the formation of PCNA-Ub1 ([@B51]). However, it is potentially deleterious (mutagenic) to trigger the formation of PCNA-Ub1 for the recruitment of Pol η during the repair synthesis after the processing of any mismatch subject to MMR ([@B52]). To reconcile these two notions, one should conclude that 8-oxoG in ssDNA specifically initiates the molecular cascade that results in the formation of PCNA-Ub1. Clearly, we suggest that Pol δ efficiently bypasses 8-oxoG in 'replication mode', but may stall or pause at the same lesion in 'gap-filling-repair mode'. It should be noted that purified Pol δ poorly replicates through 8-oxoG *in vitro* showing two strong stall sites, one right before the lesion and the other opposite to the lesion ([@B27]). In this model, Pol δ would initiate the gap-filling reaction and stall (pause) at 8-oxoG, thus allowing the recruitment of Rad18--Rad6 and the formation PCNA-Ub1.

Finally, Pol η binds to PCNA-Ub1 and catalyzes the incorporation of dCMP opposite to 8-oxoG. Here, we show that the UBZ of Pol η is essential to prevent 8-oxoG-induced mutagenesis, but only in conjunction with a functional PIP motif. This notion is based on the analysis of the properties of the D570A mutation in the UBZ domain of Pol η ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}) ([@B37]). However, this notion appeared to be at variance with the conclusions of another study reporting that mutations in the zinc-binding motif of the UBZ domain of Pol η such as CC552/553AA or HH568/572AA do not impair its TLS function *in vivo* ([@B47]), leading to the concept that the direct binding of the ubiquitin moiety on PCNA via the UBZ was not required for TLS by Pol η in *S. cerevisiae* ([@B47]). According to this study, the invalidation of the zinc-finger structure in the UBZ domain of Pol η should necessarily result in the loss of its ubiquitin-binding ability ([@B47]). Here we show that Pol η -HH568/572AA not only exhibits functional TLS of 8-oxoG, but is also capable of productively interacting with the ubiquitin moiety of PCNA-Ub1, like the WT ([Figures 3](#F3){ref-type="fig"} and 4). Even thought ubiquitin is not attached to its natural position (K164) on PCNA, our data strongly suggest that the zinc-finger structure of the UBZ domain of Pol η is not required for binding to the ubiquitin moiety of PCNA and hence for TLS in *S. cerevisiae*. It should be noted that the presence of a Zn-finger structure in the UBZ domain of Pol η from *S. cerevisiae* is not firmly demonstrated: (i) to the best of our knowledge, there is no structure of the UBZ domain of yeast Pol η (there is in fact one of the human UBZ domain, which does bind Zn) ([@B31]) and (ii) the sequence is poorly conserved, since the two cysteines are contiguous in *S. cerevisiae* (**CC**KY) versus (**C**EK**C**) in the human protein. Indeed, we cannot exclude the possibility that Pol η\'s UBZ domain in *S. cerevisiae* does not harbor any zinc at all, in analogy to the RING-like, but zinc-less U-box domain ([@B53]). Taken together, our results are compatible with the hypothesis that points to an essential role of PCNA-Ub1 and its recognition by the UBZ and PIP domains of Pol η to prevent UVC- and 8-oxoG-induced mutagenesis in *S. cerevisiae*. These conclusions may or may not be applicable to mammalian system where mutation in the Zn-finger of the UBZ domain of the human Pol η results in different phenotypes, since the H654A is TLS-deficient, whereas H650A is TLS-proficient ([@B54]).

To summarize, our current model for the late steps of the error-free bypass of 8-oxoG is as follows: (i) Pol δ in the 'gap-filling-repair' mode transiently stalls at 8-oxoG, (ii) Rad18--Rad6 is recruited at RPA-coated ssDNA allowing the formation of PCNA-Ub1, (iii) Pol η through its UBZ and PIP domains binds to PCNA-Ub1, (iv) Pol η preferentially incorporates dCMP opposite to 8-oxoG, (v) PCNA is deubiquitylated allowing the release of Pol η. When one of the components of the fidelity system that favors the recruitment of Pol η is missing the equilibrium is shifted in favor of Pol δ, which will finally lead to the mutagenic incorporation of dAMP opposite to the lesion. In *S. cerevisiae*, the complexity of the network orchestrated by Ogg1 points to 8-oxoG as a major cellular threat. In mammals, the inactivation of two major components of the network, that prevents mutation at 8-oxoG, namely Ogg1 and Myh1, results in a high incidence of cancer ([@B55]).
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[^1]: ^a^Construction of strains BU001 to BU017 is detailed in the 'Materials and Methods' section.

[^2]: Rates of mutation at the *CAN1* locus were determined from the number of Can^R^ mutant colonies by the method of the median ([@B39]). The numbers in parentheses indicate the low and high values for the 95% confidence interval for each rate.

[^3]: ^a^Ratio is relative to wild type.

[^4]: ^b^Indicate synergism (more than 2-fold the additivity) between *ogg1* and another mutation.

[^5]: ^a^Can^R^ mutation rates are the product of the proportion of a specific class of mutation and the total mutation rate for each strain ([Table 2](#T2){ref-type="table"}).

[^6]: ^b^Number in the brackets is the fold induction of GC to TA relative to the WT value.

[^7]: ^c^Complex mutation is a mutation that is composed of more than one molecular event.

[^8]: Rates of forward mutation at the *CAN1* locus were determined from the number of Can^R^ mutant colonies by the method of the median ([@B39]). The numbers in parentheses indicate the low and high values for the 95% confidence interval for each rate.

[^9]: ^a^Ratio is relative to wild type.

[^10]: Rates of forward mutation at the *CAN1* locus were determined from the number of Can^R^ mutant colonies by the method of the median ([@B39]). The numbers in parentheses indicate the low and high values for the 95% confidence interval for each rate.

[^11]: ^a^Ratio is relative to wild type.
